Gracell Biotechnologies Inc (was acquired by AstraZeneca (NASDAQ: AZN) on 20/02/2024)) (GRCL)
(35% Negative) Gracell Biotechnologies Inc (was acquired by AstraZeneca (NASDAQ: AZN) on 20/02/2024)) (GRCL) Files Form 6-K
(35% Negative) Gracell Biotechnologies Inc (was acquired by AstraZeneca (NASDAQ: AZN) on 20/02/2024)) (GRCL) Files Form 6-K
🌍 Gracell Biotechnologies Inc (was acquired by AstraZeneca (NASDAQ: AZN) on 20/02/2024)) (GRCL) - Form 6-K Filing
Filing Date: 2022-08-01
Accepted: 2022-08-01 16:01:59
Event Type: Other Event
Event Details:
💼 Business Developments:
No specific business developments reported in this filing.